Irritable bowel syndrome in children: Current knowledge, challenges and opportunities

• Published in: World journal of gastroenterology : WJG Vol. 24; no. 21; pp. 2211 - 2235
• Main Authors: Devanarayana, Niranga Manjuri, Rajindrajith, Shaman
• Format: Journal Article
• Language: English
• Published: United States Baishideng Publishing Group Inc 07-06-2018
• Subjects: Review; Functional gastrointestinal disorder; Patho-physiology; Microbiota; Post-infectious; Irritable bowel syndrome; Abdominal pain; Management
• ISSN: 1007-9327; 2219-2840
• DOI: 10.3748/wjg.v24.i21.2211

Irritable bowel syndrome (IBS) is a common and troublesome disorder in children with an increasing prevalence noted during the past two decades. It has a significant effect on the lives of affected children and their families and poses a significant burden on healthcare systems. Standard symptom-based criteria for diagnosis of pediatric IBS have changed several times during the past two decades and there are some differences in interpreting symptoms between different cultures. This has posed a problem when using them to diagnose IBS in clinical practice. A number of potential patho-physiological mechanisms have been described, but so far the exact underlying etiology of IBS is unclear. A few potential therapeutic modalities have been tested in children and only a small number of them have shown some benefit. In addition, most of the described patho-physiological mechanisms and treatment options are based on adult studies. These have surfaced as challenges when dealing with pediatric IBS and they need to be overcome for effective management of children with IBS. Recently suggested top-down and bottom-up models help integrating reported patho-physiological mechanisms and will provide an opportunity for better understanding of the diseases process. Treatment trials targeting single treatment modalities are unlikely to have clinically meaningful therapeutic effects on IBS with multiple integrating patho-physiologies. Trials focusing on multiple combined pharmacological and non-pharmacological therapies are likely to yield more benefit. In addition to treatment, in the future, attention should be paid for possible prevention strategies for IBS.